CRISPR and Designer Babies: Editing DNA, and the Ethics of Doing It

CRISPR sounds like it belongs in a science fiction script, and the headlines about it — curing genetic disease, editing embryos, "designer babies" — sound almost as dramatic as the name. The underlying tool is more precise, and more ordinary, than the headlines suggest: it's a way of finding one exact sequence in three billion letters of DNA and cutting it, borrowed directly from a defence system bacteria have used against viruses for millions of years.

How CRISPR actually finds and cuts DNA

The system has two working parts. A short piece of "guide RNA" is programmed to match a specific DNA sequence — like a search term. It leads a protein called Cas9 to that exact spot in the genome, and Cas9 acts as molecular scissors, cutting both strands of the DNA there. Once the cell's own repair machinery goes to fix that cut, scientists can influence how it's repaired — disabling a faulty gene entirely, or supplying a corrected sequence for the cell to copy in.

Curing disease with the same tool that raises the ethics question

Sickle cell disease is caused by a single-letter error in one gene. CRISPR-based treatment edits a different gene in a patient's blood stem cells to switch on a fetal form of haemoglobin that compensates for the faulty adult version — not a fix to the original error, but a precise enough edit to relieve the disease. That precision is exactly what makes germline editing (changing an embryo, rather than an existing patient) both technically feasible and ethically fraught: the same tool that reliably fixes one gene in a treatment could, in principle, be used to select or alter traits in a future child — height, appearance, cognitive traits — that have nothing to do with treating disease.

Why the ethics debate is about consent and inequality, not just "playing God"

The strongest objections to germline editing aren't really about the technology itself — they're about who gets a say. An adult patient choosing a CRISPR treatment for their own sickle cell disease is giving informed consent for themselves. An edited embryo cannot consent to changes that will be passed to every one of their own future children. There's also a real concern about access: if trait-editing ever became technically easy, it could become available only to those who can pay for it, turning a medical tool into a new axis of inequality. Those are the two threads — irreversible inheritance and unequal access — that most serious ethical frameworks on gene editing are actually built around. If the biology behind CRISPR, and the ethical reasoning around it, is something you or your child want to properly understand rather than just summarise for an exam, that's exactly what our A-Level tutoring and undergraduate tutoring are built around — see the full learning pathway here.